Sei Investments Co. Lowers Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Sei Investments Co. cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 27.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 98,273 shares of the biotechnology company's stock after selling 36,526 shares during the period. Sei Investments Co. owned about 0.13% of Axon Enterprise worth $58,405,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Asset Dedication LLC boosted its stake in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its position in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after purchasing an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC lifted its stake in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock valued at $1,204,000 after purchasing an additional 24 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several brokerages have recently issued reports on AXON. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $604.67.

Axon Enterprise Trading Up 0.4 %

Axon Enterprise stock traded up $2.31 during trading hours on Tuesday, reaching $574.83. 272,442 shares of the company's stock were exchanged, compared to its average volume of 832,122. The firm's 50 day simple moving average is $591.98 and its 200 day simple moving average is $545.11. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $44.05 billion, a PE ratio of 148.54, a PEG ratio of 5.17 and a beta of 1.12.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.